DrBox | eHealth platform to assess patient clinical progress due to prescribed medication

Summary
The objective of prescribing medicines is to improve patient health. However, many times the expected results of medications are not achieved, which causes morbidity and mortality associated to medication use. These failures of prescription drug use have been published in numerous scientific studies and negatively affect patient health as well as cause economic damages (to patients in particular and society in general). But studies show that the majority of these failures are avoidable.
Although expenses in healthcare to treat patients are high, the prevalence of morbi-mortality associated to drug prescription is high, mostly due to the fact that patients fail to follow doctor’s instructions on prescription and/or doctors duplicating therapeutics, which includes unforeseen drug interactions that can cause harm to patients.
To this avail, FSaude, working closely with software developers, chemists, medical doctors and patients since 1960, has a team of 14 experts that have generated a 2,6M€ turnover in 2016, decided to develop an eHealth platform to assess patient clinical progress due to prescribed medication – DrBox.
There is a market opportunity in improving a pharmacist’s capacity to provide Pharmaceutical Care, through a Therapeutics Management program, in order to reduce patient’s morbi-mortality related to drug use, improve patient’s quality of life and reduce overall costs to citizens and society.
DrBox allows, for the first time in the history of modern health, the possibility for health program management entities (MD, pharmacies, nursing homes, etc.) to be able to receive in real time the epidemiological information needed to make decisions in the National Health Systems.
At the present moment DrBox is being tested in three pharmacies and one nursing home, with a total of 70.000 registered users.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/807509
Start date: 01-02-2018
End date: 31-07-2018
Total budget - Public funding: 71 429,00 Euro - 50 000,00 Euro
Cordis data

Original description

The objective of prescribing medicines is to improve patient health. However, many times the expected results of medications are not achieved, which causes morbidity and mortality associated to medication use. These failures of prescription drug use have been published in numerous scientific studies and negatively affect patient health as well as cause economic damages (to patients in particular and society in general). But studies show that the majority of these failures are avoidable.
Although expenses in healthcare to treat patients are high, the prevalence of morbi-mortality associated to drug prescription is high, mostly due to the fact that patients fail to follow doctor’s instructions on prescription and/or doctors duplicating therapeutics, which includes unforeseen drug interactions that can cause harm to patients.
To this avail, FSaude, working closely with software developers, chemists, medical doctors and patients since 1960, has a team of 14 experts that have generated a 2,6M€ turnover in 2016, decided to develop an eHealth platform to assess patient clinical progress due to prescribed medication – DrBox.
There is a market opportunity in improving a pharmacist’s capacity to provide Pharmaceutical Care, through a Therapeutics Management program, in order to reduce patient’s morbi-mortality related to drug use, improve patient’s quality of life and reduce overall costs to citizens and society.
DrBox allows, for the first time in the history of modern health, the possibility for health program management entities (MD, pharmacies, nursing homes, etc.) to be able to receive in real time the epidemiological information needed to make decisions in the National Health Systems.
At the present moment DrBox is being tested in three pharmacies and one nursing home, with a total of 70.000 registered users.

Status

CLOSED

Call topic

SMEInst-01-2016-2017

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
H2020-EU.2.1.1.0. INDUSTRIAL LEADERSHIP - ICT - Cross-cutting calls
H2020-SMEINST-1-2016-2017
SMEInst-01-2016-2017 Open Disruptive Innovation Scheme
H2020-SMEINST-2-2016-2017
SMEInst-01-2016-2017 Open Disruptive Innovation Scheme
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-1-2016-2017
SMEInst-01-2016-2017 Open Disruptive Innovation Scheme
H2020-SMEINST-2-2016-2017
SMEInst-01-2016-2017 Open Disruptive Innovation Scheme